ATE386054T1 - Glycosylierte humane interferon alpha isoform - Google Patents
Glycosylierte humane interferon alpha isoformInfo
- Publication number
- ATE386054T1 ATE386054T1 AT03791472T AT03791472T ATE386054T1 AT E386054 T1 ATE386054 T1 AT E386054T1 AT 03791472 T AT03791472 T AT 03791472T AT 03791472 T AT03791472 T AT 03791472T AT E386054 T1 ATE386054 T1 AT E386054T1
- Authority
- AT
- Austria
- Prior art keywords
- interferon alpha
- human interferon
- alpha isoform
- glycosylated human
- expression vector
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20020052365 | 2002-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE386054T1 true ATE386054T1 (de) | 2008-03-15 |
Family
ID=36241068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03791472T ATE386054T1 (de) | 2002-08-31 | 2003-08-29 | Glycosylierte humane interferon alpha isoform |
Country Status (9)
Country | Link |
---|---|
US (1) | US7311903B2 (de) |
EP (1) | EP1549675B1 (de) |
JP (1) | JP4181543B2 (de) |
KR (2) | KR20040020817A (de) |
CN (1) | CN1684979A (de) |
AT (1) | ATE386054T1 (de) |
AU (1) | AU2003256125A1 (de) |
DE (1) | DE60319114T2 (de) |
WO (1) | WO2004019856A2 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004022593A2 (en) * | 2002-09-09 | 2004-03-18 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
US7597884B2 (en) * | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
AU2005273968A1 (en) * | 2004-08-09 | 2006-02-23 | Alios Biopharma Inc. | Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same |
KR100781666B1 (ko) * | 2004-11-02 | 2007-12-03 | 신영기 | 인간 인터페론-베타 변이체 |
AR078117A1 (es) | 2006-06-20 | 2011-10-19 | Protech Pharma S A | Una muteina recombinante del interferon alfa humano glicosilado, un gen que codifica para dicha muteina, un metodo de produccion de dicho gen, un metodo para obtener una celula eucariota productora de dicha muteina, un metodo para producir dicha muteina, un procedimiento para purificar dicha muteina |
US20080260820A1 (en) * | 2007-04-19 | 2008-10-23 | Gilles Borrelly | Oral dosage formulations of protease-resistant polypeptides |
WO2010017290A1 (en) * | 2008-08-05 | 2010-02-11 | The Trustees Of Columbia University In The City Of New York | Müllerian inhibiting substance (mis) analogues |
WO2011059828A1 (en) * | 2009-10-29 | 2011-05-19 | University Of Kansas | Methods of producing and purifying proteins |
WO2011075605A2 (en) * | 2009-12-18 | 2011-06-23 | Alios Biopharma, Inc. | Hyperglycosylated interferon variants and methods of use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6610830B1 (en) * | 1980-07-01 | 2003-08-26 | Hoffman-La Roche Inc. | Microbial production of mature human leukocyte interferons |
US4931373A (en) * | 1984-05-25 | 1990-06-05 | Zymogenetics, Inc. | Stable DNA constructs for expression of α-1 antitrypsin |
US6020465A (en) * | 1993-10-22 | 2000-02-01 | University Of Connecticut | Recombinant avian type i interferon |
US5908621A (en) | 1995-11-02 | 1999-06-01 | Schering Corporation | Polyethylene glycol modified interferon therapy |
US6197350B1 (en) * | 1996-12-20 | 2001-03-06 | Takeda Chemical Industries, Ltd. | Method of producing a sustained-release preparation |
WO1999012959A1 (en) * | 1997-09-05 | 1999-03-18 | Altus Biologics Inc. | Carbohydrate crosslinked glycoprotein crystals |
-
2003
- 2003-08-29 AT AT03791472T patent/ATE386054T1/de not_active IP Right Cessation
- 2003-08-29 KR KR1020030060431A patent/KR20040020817A/ko not_active Application Discontinuation
- 2003-08-29 AU AU2003256125A patent/AU2003256125A1/en not_active Abandoned
- 2003-08-29 DE DE60319114T patent/DE60319114T2/de not_active Expired - Lifetime
- 2003-08-29 CN CNA038232618A patent/CN1684979A/zh active Pending
- 2003-08-29 JP JP2004532441A patent/JP4181543B2/ja not_active Expired - Fee Related
- 2003-08-29 WO PCT/KR2003/001765 patent/WO2004019856A2/en active IP Right Grant
- 2003-08-29 EP EP03791472A patent/EP1549675B1/de not_active Expired - Lifetime
- 2003-09-01 KR KR10-2003-0060941A patent/KR100536628B1/ko not_active IP Right Cessation
- 2003-09-02 US US10/653,350 patent/US7311903B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20050019871A1 (en) | 2005-01-27 |
KR100536628B1 (ko) | 2005-12-14 |
AU2003256125A1 (en) | 2004-03-19 |
EP1549675B1 (de) | 2008-02-13 |
WO2004019856A3 (en) | 2004-07-29 |
DE60319114D1 (en) | 2008-03-27 |
EP1549675A4 (de) | 2006-05-31 |
EP1549675A2 (de) | 2005-07-06 |
AU2003256125A8 (en) | 2004-03-19 |
CN1684979A (zh) | 2005-10-19 |
JP2006512058A (ja) | 2006-04-13 |
KR20040020830A (ko) | 2004-03-09 |
WO2004019856A2 (en) | 2004-03-11 |
KR20040020817A (ko) | 2004-03-09 |
US7311903B2 (en) | 2007-12-25 |
JP4181543B2 (ja) | 2008-11-19 |
DE60319114T2 (de) | 2008-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA01010360A (es) | Produccion de proteinas recombinantes en una celula humana. | |
ATE470702T1 (de) | Verfahren zur herstellung von permanenten humanen zelllinien | |
IN2014CN02050A (de) | ||
BRPI0411475A (pt) | adições de código genético de aminoácido reativo não natural | |
SG170116A1 (en) | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides | |
IL196893A0 (en) | Site specific incorporation of non-natural amino acids by vertebrate cells | |
GB2431404A (en) | Peptide | |
EP2402369A3 (de) | Peptidfragmente zur Induzierung der Synthese extrazellulärer Matrixproteine | |
HUP0402164A2 (hu) | Ellenanyagok policisztronos expresszáltatása | |
BRPI0416744A (pt) | sistemas de expressão de proteìna aperfeiçoados | |
NO20082716L (no) | Sammensetninger og fremgangsmater for fremstilling av en sammensetning | |
MX348154B (es) | Anticuerpos de enlace a il-1-beta y fragmentos de los mismos. | |
BRPI0410164A (pt) | composições e métodos para preparação de mutantes de glicosilação de hormÈnio do crescimento humano | |
ATE462000T1 (de) | Verfahren zur herstellung von l-arginin, l- ornithin oder l-citrullin | |
AR020735A1 (es) | Un procedimiento para la obtencion de un polipeptido glucosilado a partir de celulas eucarioticas | |
ATE386054T1 (de) | Glycosylierte humane interferon alpha isoform | |
TNSN05187A1 (en) | Overexpression vector for animal cell | |
ATE246247T1 (de) | Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität | |
DK1194575T3 (da) | Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling heraf | |
WO1997006247A3 (en) | Deubiquitinating enzymes that regulate cell growth | |
WO2004020576A3 (en) | Glycosylated human granulocyte colony-stimulating factor (g-csf) isoform | |
WO2008041014A3 (en) | Interferon- alpha constructs for use in the treatment of diseases characterised by abnormal cell proliferation such as cancer | |
NZ586037A (en) | Sm-protein based secretion engineering | |
WO2005034876A3 (en) | Use of cell lines to produce active therapeutic proteins | |
CY1108849T1 (el) | Πολλαπλασιαμος του ιου κορωνα των βοοειδων σε κυτταρα ωοθηκων κινεζικων κρικητων |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |